8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study was designed to determine an optimal dose range for the once-daily dosing (ODD) of tobramycin in the treatment of an acute pulmonary exacerbation in paediatric cystic fibrosis (CF) patients. In addition, we aimed to assess whether certain patient characteristics affect tobramycin pharmacokinetics and, therefore, dosing.

          Related collections

          Author and article information

          Journal
          J. Antimicrob. Chemother.
          The Journal of antimicrobial chemotherapy
          Oxford University Press (OUP)
          0305-7453
          0305-7453
          Jun 2007
          : 59
          : 6
          Affiliations
          [1 ] Department of Pharmacy Services, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
          Article
          dkm097
          10.1093/jac/dkm097
          17446242
          83b182f1-5ef7-46cd-ba78-dbb5f30e5637
          History

          Comments

          Comment on this article